https://www.marketscreener.com/quote/stock/ELEVATION-ONCOLOGY-INC-124120295/news/Elevation-Oncology-Expands-Ongoing-Phase-1-Clinical-Trial-of-EO-3021-Globally-Dosing-First-Patient-46009079/?utm_source=telegram&utm_medium=social&utm_campaign=share